Bank Vontobel AG Share Price

RMAS7V

CH1315861554

Market Closed - Swiss Exchange 08:50:00 27/06/2024 pm IST
98.9 ^USD	+0.10%

1 month	-0.90%
3 months	-2.08%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart BRISTOL-MYERS SQUIBB COMPANY

Latest news about BRISTOL-MYERS SQUIBB COMPANY

Purple Biotech Says Interim Data from Pancreatic Cancer Drug Study Shows Promise	27/06	MT
2seventy bio Sells Hemophilia A Candidate, Gene Editing Technology to Novo Nordisk; Shares Rise After Hours	27/06	MT
Top Midday Stories: Southwest Cuts Q2 Guidance; HHS to Lower Costs for Medicare Enrollees on 64 Drugs; Bosch Weighing Acquisition Offer for Whirlpool; Novo Nordisk to Record $816.2 Million Impairment	26/06	MT
Biden Administration to Lower Costs for 64 Prescription Drugs for Medicare Enrollees	26/06	MT

More news

Quotes 5-day view

Date	Price	Change
27/24/27	98.9	+0.10%
24/24/24	98.8	+0.51%

Delayed Quote Swiss Exchange

Last update June 27, 2024 at 08:50 pm IST

More quotes

Static data

Product type	Aktienanleihen
Buy / Sell	CALL
Underlying	BRISTOL-MYERS SQUIBB COMPANY
Issuer	Vontobel
	RMAS7V
ISIN	CH1315861554
Date issued	01/03/2024
Strike	50.89 $
Maturity	02/09/2025 (431 Days)
Parity	0.05 : 1
Emission price	100 $
Emission volume	N/A
Settlement	Beides
Currency	USD

Technical Indicators

Highest since issue	101 $
Lowest since issue	97 $
Spread	8 $
Spread %	0.80%

Company Profile

Bristol-Myers Squibb Company est spécialisé dans le développement, la fabrication et la commercialisation de produits pharmaceutiques. Les produits sont destinés au traitement des cancers, des maladies cardio-vasculaires, de l'hépatite, des maladies immunitaires et des désordres psychiatriques. The United States account for 70.1% of net sales.

Sector

More about the company

Ratings for Bristol-Myers Squibb Company

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Consensus: Bristol-Myers Squibb Company

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

41.53 USD

Average target price

53.19 USD

Spread / Average Target

+28.09%

Consensus